@idean You said: “ Why don't we all wait and see the execution phase continue to actualise before making any comments as to how well it's working or not, instead of daily commentary based on ??? (ill-informed, assumptions, best-guesses, or whatever the arm-chair keyboard warriors are providing).”
And whilst it’s early in the execution phase, that’s exactly why I haven’t posted here for 5 days. In the interim, the number of posts on this SPL forum are increasing exponentially. But whilst many posts are well meaning, many are actually ill-informed, or naive, or are blatant ramping and many are based on meaningless optimistic, best case assumptions.
As always, anyone that dare questions the bonafides of the product or marketing strategy is labelled a heretic.
I am no sales and marketing doyen but if
anyone can espouse the virtues of ‘holding Viraleze back’ from Lloyds in-store sales (for another 2 weeks in a pandemic) until there’s enough product for 1400 stores across the UK; as opposed to launching in-store now or last week with much media fanfare and publicity in a flagship Lloyds Pharmacy store in central London, then I’m all ears.
P.S. I’m waiting for a reply from Lloyds Pharmacy UK for confirmation about their strategy and plans for in-store roll out. I’ll let you all know if I get a response.
P.S.S. In the meantime, by all means be positive and dream of our pending success and riches (I want that too), but stay away from the kool-aid, put the rose coloured glasses away and DYOR and thinking.
P.S.S.S. If you have a query or are not entirely happy with any aspect of Starpharma then don’t be shy or wary of the Hotcopper pom pom mob. Post it here on Hotcopper or email investor relations (good luck). After all this is OUR company, not Jackie’s or the BODs.
GLTAH
